申请人:——
公开号:US20020151534A1
公开(公告)日:2002-10-17
Antithrombotic compounds of general formula
1
Exemplary are:
(1) 2-(5-carbamimidoyl-2-hydroxy-phenyl)-N-[
3
-methyl-4-(pyrrolidin-1-yl-carbonyl)-phenyl]-ethylamine,
(2) N-(5-carbamimidoyl-2-hydroxy-benzyl)-3-methyl-4-(pyrrolidin-1-yl-carbonyl)-benzylamine, and
(3) N-(5-carbamimidoyl-2-hydroxy-benzyl)-2,5-dimethyl-4-(pyrrolidin-1-yl-carbonyl)-benzylamine.
通用公式1的抗血栓化合物示例包括:(1) 2-(5-羰基基-2-羟基苯基)-N-[3-甲基-4-(吡咯啉-1-基羰基)苯基]-乙胺,(2) N-(5-羰基基-2-羟基苄基)-3-甲基-4-(吡咯啉-1-基羰基)-苄胺,和(3) N-(5-羰基基-2-羟基苄基)-2,5-二甲基-4-(吡咯啉-1-基羰基)-苄胺。